EUVIMED · CrossrefZeitschrift
Breast Cancer
ISSN 1340-6868 · Springer Science and Business Media LLC
Neueste Artikel
Claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan
Real-world outcomes of everolimus-based therapy after CDK4/6 inhibitor therapy in ER-positive/HER2-negative metastatic breast cancer: a multicenter registry-based study
Feasibility and safety of intraoperative photodynamic diagnosis using 5-aminolevulinic acid in breast cancer surgery
Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 − metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study
Nonlinear association between age and volumetric breast density in Japanese women
Predicting neoadjuvant chemotherapy efficacy in triple-negative breast cancer using DCE-MRI and mammographic texture
Methodological considerations in evaluating bioelectrical impedance and quality of life in breast cancer: NACT confounding, generalizability of standing devices, and fluid asymmetries
Association between preoperative body composition and health-related quality of life in breast cancer patients: a prospective Eastern European study
Perioperative outcomes of CO2 insufflation and retractor-assisted endoscopic nipple-sparing mastectomy: a single-institution retrospective study
Evaluations of significant loci associated with mammographic breast density in Korean women
Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients
Evaluation of serum microRNA-9-5p expression and its predicted target genes as potential biomarkers for breast cancer
Real-world analysis of interstitial lung disease/pneumonitis in Japanese patients with breast cancer receiving trastuzumab deruxtecan
Evaluating high-risk breast cancer surveillance outcomes in BRCA mutation carriers
Scaffold-based breast conserving surgery in patients with non-malignant breast lesions: long-term follow-up of a first-in-human pilot study on the REGENERA™ biomimetic breast implant
Breast reconstruction-related complications from postmastectomy radiation therapy in stage II–III breast cancer: sub-analysis of a multi-institutional observational study (Reborn-03)
Patterns of ipsilateral breast tumor recurrence following partial vs. whole-breast irradiation: a retrospective comparative study of breast-conserving therapy
Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer
Postmastectomy radiation therapy for implant-based breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese Breast Cancer Society Clinical Practice Guideline
Stereotactic radiosurgery for HER2-positive breast cancer brain metastases: prognostic factors and the evolving role of anti-HER2 therapies
Comparison of transcriptome profiles of radiotherapy beams on MCF-7 breast cancer xenografts
Effects of CBT-based interventions on health outcomes in breast cancer patients: a systematic review and Meta-analysis
Effects of breast size on breast reconstruction in BRCA mutation carriers and genetic high-risk patients after bilateral mastectomy
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry—clinical implications including chemosensitivity of breast cancer with low estrogen receptor expression
Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort
Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)
Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study
Jahrgänge
2026 · 1292025 · 1492024 · 1242023 · 1092022 · 1152021 · 1472020 · 1402019 · 1042018 · 1002017 · 1082016 · 1242015 · 922014 · 1122013 · 592012 · 602011 · 552010 · 582009 · 572008 · 582007 · 742006 · 692005 · 682004 · 692003 · 632002 · 642001 · 592000 · 721999 · 691998 · 661997 · 551996 · 351995 · 211994 · 24
EUVIMED